Media Summary: An Interview with Dr. Günter Jagschies, business advisor for the GE BioProcess teams. Currently, the Jared Holz, Mizuho healthcare sector strategist, joins 'Squawk Box' to discuss the Deep Pharma Intelligence held a 3-day virtual event (November 15-17), which was a unique

The Main Opportunities And Challenges In The Rapidly Evolving Asian Biopharma Markets - Detailed Analysis & Overview

An Interview with Dr. Günter Jagschies, business advisor for the GE BioProcess teams. Currently, the Jared Holz, Mizuho healthcare sector strategist, joins 'Squawk Box' to discuss the Deep Pharma Intelligence held a 3-day virtual event (November 15-17), which was a unique China's pharmaceutical industry is booming — and Big Pharma can't look away. From groundbreaking ... so many different mechanisms and so many different assets both biologic and small molecule the Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own

Listen to our distinguished speaker, Nancy Sacco- VP Clinical Development from Xentria, Inc. as she discusses about ... ImmunityBio: Why Macau Could Be ANKTIVA's Gateway Into

Photo Gallery

THE MAIN OPPORTUNITIES AND CHALLENGES IN THE RAPIDLY EVOLVING ASIAN BIOPHARMA MARKETS?
Asia’s booming biopharma market | Interview with Chervee Ho & Peter Soelkner | CDMO Insights
Biopharma Market Insights |  Asia Market
Biopharma Market Insights | Emerging Markets
Pharma's agenda in Washington: Here are the challenges and opportunities
The Rise of Advanced Technologies in the Pharmaceutical Industry - Day 3 (West) - Ihor Kendiukhov
'Fast Money' traders talk how to play biopharma space
Global Biopharma Shift: US, EU & China Explained
Welcome to Evaluating Biopharma's - Technology's Evolution and Impact on Manufacturing Conference
China’s Pharma Surge: How It’s Challenging Big Pharma | CNA Correspondent
Asia  - Key Trends in Biotech and Pharma
Biopharma Dealmaking 2026 Trends, Shifts, and What Comes Next
Sponsored
Sponsored
View Detailed Profile
THE MAIN OPPORTUNITIES AND CHALLENGES IN THE RAPIDLY EVOLVING ASIAN BIOPHARMA MARKETS?

THE MAIN OPPORTUNITIES AND CHALLENGES IN THE RAPIDLY EVOLVING ASIAN BIOPHARMA MARKETS?

An Interview with Dr. Günter Jagschies, business advisor for the GE BioProcess teams. Currently, the

Asia’s booming biopharma market | Interview with Chervee Ho & Peter Soelkner | CDMO Insights

Asia’s booming biopharma market | Interview with Chervee Ho & Peter Soelkner | CDMO Insights

The

Sponsored
Biopharma Market Insights |  Asia Market

Biopharma Market Insights | Asia Market

Asia Biopharma Market

Biopharma Market Insights | Emerging Markets

Biopharma Market Insights | Emerging Markets

Global

Pharma's agenda in Washington: Here are the challenges and opportunities

Pharma's agenda in Washington: Here are the challenges and opportunities

Jared Holz, Mizuho healthcare sector strategist, joins 'Squawk Box' to discuss the

Sponsored
The Rise of Advanced Technologies in the Pharmaceutical Industry - Day 3 (West) - Ihor Kendiukhov

The Rise of Advanced Technologies in the Pharmaceutical Industry - Day 3 (West) - Ihor Kendiukhov

Deep Pharma Intelligence held a 3-day virtual event (November 15-17), which was a unique

'Fast Money' traders talk how to play biopharma space

'Fast Money' traders talk how to play biopharma space

The '

Global Biopharma Shift: US, EU & China Explained

Global Biopharma Shift: US, EU & China Explained

How are global policy changes reshaping

Welcome to Evaluating Biopharma's - Technology's Evolution and Impact on Manufacturing Conference

Welcome to Evaluating Biopharma's - Technology's Evolution and Impact on Manufacturing Conference

The

China’s Pharma Surge: How It’s Challenging Big Pharma | CNA Correspondent

China’s Pharma Surge: How It’s Challenging Big Pharma | CNA Correspondent

China's pharmaceutical industry is booming — and Big Pharma can't look away. From groundbreaking

Asia  - Key Trends in Biotech and Pharma

Asia - Key Trends in Biotech and Pharma

Asia

Biopharma Dealmaking 2026 Trends, Shifts, and What Comes Next

Biopharma Dealmaking 2026 Trends, Shifts, and What Comes Next

... so many different mechanisms and so many different assets both biologic and small molecule the

Biopharma Market Insights |  Russia Market

Biopharma Market Insights | Russia Market

Global

How This New Biotech Billionaire Outmaneuvered Merck In China

How This New Biotech Billionaire Outmaneuvered Merck In China

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own

Challenges for Small Biotech's Operating Like Large Pharma & Selecting/Partnering With the Right CRO

Challenges for Small Biotech's Operating Like Large Pharma & Selecting/Partnering With the Right CRO

Listen to our distinguished speaker, Nancy Sacco- VP Clinical Development from Xentria, Inc. as she discusses about ...

Biopharma Market Insights | LATAM Markets

Biopharma Market Insights | LATAM Markets

The global

Biopharma Market Insights | Korea Market

Biopharma Market Insights | Korea Market

Global

ImmunityBio: Why Macau Could Be ANKTIVA’s Gateway Into Asia

ImmunityBio: Why Macau Could Be ANKTIVA’s Gateway Into Asia

ImmunityBio: Why Macau Could Be ANKTIVA's Gateway Into

📍North Carolina’s biotech ecosystem is evolving fast.

📍North Carolina’s biotech ecosystem is evolving fast.

artotalent #ARTOTalent #ai #lifesciences #biotechnology #investment #ARTOInsights #machinelearning #dermatology #funds ...